Laddar...
Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study
OBJECTIVE: To assess the eligibility of patients participating in DISCOVER (a 3-year, prospective, observational study program of 15 992 patients with type 2 diabetes [T2D] initiating a second-line glucose-lowering therapy across 38 countries) for four cardiovascular outcomes trials (CVOTs) of sodiu...
Sparad:
| I publikationen: | BMJ Open Diabetes Res Care |
|---|---|
| Huvudupphovsmän: | , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BMJ Publishing Group
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501855/ https://ncbi.nlm.nih.gov/pubmed/31114700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2018-000627 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|